CNBC February 8, 2024
Key Points
– Shares of 23andMe sank Thursday, a day after the company reported dismal third-quarter fiscal 2024 results and discussed splitting itself in two to help juice its stock price.
– 23andMe reported revenue of $44.7 million for the quarter, down from $66.9 million in the year-ago period.
– In November, 23andMe received a deficiency letter from the Nasdaq Listing Qualifications Department giving the company 180 days to bring its share price back above $1.
– CEO Anne Wojcicki said the company is considering splitting up its consumer and therapeutics businesses to help expand its investor base.
Shares of 23andMe closed down 13% on Thursday, a day after the genetic testing company reported dismal fiscal third-quarter results and discussed...
Today's Sponsors
Today's Sponsor